PMC5514191_01
External photograph of the solitary lesion involving the left upper lid
OC-07-19-g-001.jpg
PMC5514191_01_OC-07-19-g-001.jpg
F1
The left eyelid showed a localized swelling confined to the tarsal region with a slight yellowish tinge seen over the skin (Figure 1 (Fig. 1)).
Histopathological examination showing polymorphs and neutrophilic microabscess
OC-07-19-g-002.jpg
PMC5514191_01_OC-07-19-g-002.jpg
F2
Excision biopsy was done and the sample was sent for histopathological examination which revealed a mixture of cells including polymorphs, plasma cells (Figure 2 (Fig. 2)), foamy macrophages (Figure 3 (Fig. 3)), and occasional
Histopathology showing foamy macrophages and plasma cells
OC-07-19-g-003.jpg
PMC5514191_01_OC-07-19-g-003.jpg
F3
Excision biopsy was done and the sample was sent for histopathological examination which revealed a mixture of cells including polymorphs, plasma cells (Figure 2 (Fig. 2)), foamy macrophages (Figure 3 (Fig. 3)), and occasional
Histopathology showing Touton giant cell
OC-07-19-g-004.jpg
PMC5514191_01_OC-07-19-g-004.jpg
F4
Touton type of giant cells (Figure 4 (Fig. 4)).
PMC5514191_02
External photographs of the solitary lesion in the left eye
OC-07-19-g-005.jpg
PMC5514191_02_OC-07-19-g-005.jpg
F5
A 31-year-old female came with complaints of two pigmented painless lesions on her left upper eyelid since a few years (Figure 5 (Fig. 5)).
Histopathology showing mononucleated foamy histiocytes (xanthoma cells), aggregates of lymphocytes, plasma cells, and Touton giant cells
OC-07-19-g-006.jpg
PMC5514191_02_OC-07-19-g-006.jpg
F6
Excision biopsy was advised which revealed plasma cells, touton cells and foamy histiocytes suggestive of a xanthogranulomatous inflammation (Figure 6 (Fig. 6), Figure 7 (Fig. 7)).
Magnified image (40x) showing the Touton cell
OC-07-19-g-007.jpg
PMC5514191_02_OC-07-19-g-007.jpg
F7
Excision biopsy was advised which revealed plasma cells, touton cells and foamy histiocytes suggestive of a xanthogranulomatous inflammation (Figure 6 (Fig. 6), Figure 7 (Fig. 7)).